Doç. Dr. Hüseyin Akyol

Berufserfahrung

• 2024-HalenMedicana Zincirlikuyu Hastanesimedicana.com.tr
• 2019-2024Altınbaş Üniversitesi Tıp Fakültesi (Dekan Yardımcısı)medicana.com.tr
• 2007-2024Medical Park Bahçelievler Hastanesi, Dr. Öğretim görevlisimedicana.com.tr
• 2005-2007Kırşehir Devlet Hastanesi, Uzman Dr.medicana.com.tr
• 2000-2005Dr. Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi, Asistan Dr.medicana.com.tr

Ausbildung

• 1998Uludağ Üniversitesi Tıp Fakültesimedicana.com.tr
• 2005Dr. Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesimedicana.com.tr

• FachgebietAllgemeinchirurgiemedicana.com.trAus der Quelle
• Abteilungsname in der QuelleObezite ve Metabolik Cerrahimedicana.com.trAus der Quelle
• EinrichtungMedicana Zincirlikuyumedicana.com.trAus der Quelle
• Publikationen29 PublikationenProfilseite auf medicana.com.trAus der Quelle
• Letzte Synchronisierung7. November 2026 03:22https://www.medicana.com.tr/hekim-detay/21831/huseyin-akyolmedicana.com.tr

1. 1.Akyol Hüseyı̇n, Erok Berrı̇n (2021). Factors Affecting the Selection of the Bariatric Surgeon-A Survey Study. International Journal of Clinical Case Reports and Reviews, 9(2), 1-5. Doi: 10.31579/2690-4861/172

   Quelle: Profilseite auf medicana.com.tr

2. 2.Akyol Hüseyı̇n, Erok Berrı̇n (2021). Quality of Information Available on YouTube Videos Pertaining to Bariatric Surgery. International Journal of Clinical Case Reports and Reviews, 9(2), 1- 6. Doi: 10.31579/2690-4861/173

   Quelle: Profilseite auf medicana.com.tr

3. 3.Aydın MA, Akyol H (2020). Quality of Information Available on YouTube Videos Pertaining to Thyroid Cancer. Journal of Cancer Education, 35(3), 599-605. Doi: 10.1007/s13187- 019-01502-9

   Quelle: Profilseite auf medicana.com.tr

4. 4.Yanmaz MT, İzmı̇r GŞ, Satılmış B, Akyol H, Aydın MA (2014). Thirty-minutes infusion rate is safe enough for bevacizumab; no need for initial prolong infusion. Medical Oncology, 31(11), 1-5. Doi: 10.1007/s12032-014-0276-1

   Quelle: Profilseite auf medicana.com.tr

5. 5.Küçük HF, Gülmez S, Kaptanoğlu L, Akyol H, Kurt N, Yavuzer D. (2009) ‘Acute Abdomen Due to Rupture of Hemangiopericytoma of the Greater Omentum: Case Report’’, Ulus Travma Acil Cerrahi Derg, 15, 611-613.

   Quelle: Profilseite auf medicana.com.tr

6. 6.KaptanoğLu L, Küçük HF, Çolak E, Kurt N, Bı̇ngül SM, Akyol H, Torlak OA, Yazıcı F (2008). The effect of taurolidine on experimental thrombus formation. European Journal of Pharmacology, 578(2), 238-241. Doi: 10.1016/j.ejphar.2007.08.035

   Quelle: Profilseite auf medicana.com.tr

7. 7.Küçük HF, KaptanoğLu L, Kurt N, Uzun H, Eser M, Bı̇ngül S, Torlak OA, Akyol H (2007). The Role of Simvastatin on Postoperative Peritoneal Adhesion Formation in an Animal Model. European Surgical Research, 39(2), 98-102. Doi: 10.1159/000099156

   Quelle: Profilseite auf medicana.com.tr

8. 8.Küçük HF, Bı̇ngül SM, Kurt N, KaptanoğLu L, Akyol H, Torlak OA, Çolak E (2006). Effect of a Selective Cyclooxygenase-2 Inhibitor on Renal Scarring. European Surgical Research, 38(5), 451-457. Doi: 10.1159/000095088

   Quelle: Profilseite auf medicana.com.tr

9. 9.Küçük HF, KaptanoğLu L, Özalp F, Kurt N, Bingül SM, Torlak OA, Çolak E, Akyol H, Ege GA (2006). Role of Glyceryl Trinitrate, a Nitric Oxide Donor, in the Renal Ischemia-Reperfusion Injury of Rats. European Surgical Research, 38(5), 431-437. Doi: 10.1159/000095085

   Quelle: Profilseite auf medicana.com.tr

10. 10.Küçük HF, Akyol H, KaptanoğLu L, Kurt N, Özdemı̇r BN, Bı̇ngül S, Torlak OA, Çolak E (2006). Effect of Proton Pump Inhibitors on Hepatic Regeneration. European Surgical Research, 38(3), 322-328. Doi: 10.1159/000094020

    Quelle: Profilseite auf medicana.com.tr